In particular, only three molecules behave differently in CHD and LC patients: β-NGF is higher in LC whereas glucagon and IL-18 are higher in CHD (with p-value <0.05) (Figure 3). The gene discussed is GCG; the disease is laryngotracheoesophageal cleft.